Among them, 6 patients had TP53 variants, and their TP53 variants co-existed in the ctDNA and DNA from tumor biopsies (Supplementary Table S1 and Supplementary Figure S2), suggesting the TP53 variants origin from breast cancer, not CHIP mutations. The gene discussed is TP53; the disease is breast carcinoma.